Same company selling same drug under different brand names and at different prices is even more inexplicable.
MUST READ
The department of telecommunications (DoT) has sought clarifications…
Indian pharma giants like Glenmark, Sun, Dr Reddy’s and others are betting on the first-to-files.
Decks have been cleared for the approval of R5,500-crore worth foreign direct investment proposals in brownfield pharmaceutical projects involving transfer…
Drug price regulator asked to consider antiseptic liquid emulsion and not elixir
In its latest submission to the department of industrial policy and promotion (DIPP) last week, US-based Mylan said that the…
US FDA has asked Torrent Pharmaceuticals to recall Olanzapine tablets.
History shows that production cuts are more common in the govt sector than among private firms
Pioglitazone has market sales of over R800 crore, whereas analgin is a mere Rs 40 crore.
The Department of Pharmaceuticals (DoP) is clear that drug companies will not be allowed to sell old stocks of essential…
Loading…
Something went wrong. Please refresh the page and/or try again.
